Exhibit 10.2
THE MEDICINES COMPANY
Nonstatutory Stock Option Agreement
Under 2004 Stock Incentive Plan
1. Grant of Option .
(a) This agreement evidences the grant by The Medicines Company, a Delaware corporation (the
“Company”), on , 2004 (the “Grant Date”) to , an [employee], [consultant] of the
Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in
the Company’s 2004 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common
stock, $0.001 par value per share (“Common Stock”), of the Company at a price of __DOCTEXT__nbsp; per Share.
Unless earlier terminated, this option shall expire on the tenth anniversary of the Grant Date (the “Final Exercise
Date”).
(b) It is intended that the option evidenced by this agreement shall not be an incentive stock option
as defined in Section 422 of the Internal Revenue Code of 1986, as amended and any regulations promulgated
thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this
option, shall be deemed to include any person who acquires the right to exercise this option validly under its
terms.
2. Vesting Schedule .
(a) This option will become exercisable (“vest”) in equal monthly installments in arrears over the
four-year period commencing on the Grant Date. This option shall expire upon, and will not be exercisable after,
the Final Exercise Date.
(b) The right of exercise shall be cumulative so that to the extent the option is not exercised in any
period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to
all Shares for which it is vested until the earlier of the